These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20636633)

  • 21. Meta-analysis of functional magnetic resonance imaging studies of timing and cognitive control in schizophrenia and bipolar disorder: Evidence of a primary time deficit.
    Alústiza I; Radua J; Pla M; Martin R; Ortuño F
    Schizophr Res; 2017 Oct; 188():21-32. PubMed ID: 28169089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications.
    Burdick KE; Russo M; Frangou S; Mahon K; Braga RJ; Shanahan M; Malhotra AK
    Psychol Med; 2014 Oct; 44(14):3083-96. PubMed ID: 25065409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Executive functioning in schizophrenia: a thorough examination of performance on the Hayling Sentence Completion Test compared to psychiatric and non-psychiatric controls.
    Joshua N; Gogos A; Rossell S
    Schizophr Res; 2009 Oct; 114(1-3):84-90. PubMed ID: 19541454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder.
    Bowie CR; Depp C; McGrath JA; Wolyniec P; Mausbach BT; Thornquist MH; Luke J; Patterson TL; Harvey PD; Pulver AE
    Am J Psychiatry; 2010 Sep; 167(9):1116-24. PubMed ID: 20478878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impairment in functional capacity as an endophenotype candidate in severe mental illness.
    Harvey PD; McClure MM; Patterson TL; McGrath JA; Pulver AE; Bowie CR; Siever LJ
    Schizophr Bull; 2012 Nov; 38(6):1318-26. PubMed ID: 21562142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased Cingulate Cortex activation during cognitive control processing in bipolar disorder.
    Gruber SA; Dahlgren MK; Sagar KA; Gonenc A; Norris L; Cohen BM; Ongur D; Lewandowski KE
    J Affect Disord; 2017 Apr; 213():86-95. PubMed ID: 28199893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder.
    Reilly JL; Hill SK; Gold JM; Keefe RS; Clementz BA; Gershon E; Keshavan MS; Pearlson G; Tamminga CA; Sweeney JA
    Schizophr Bull; 2017 Mar; 43(2):397-406. PubMed ID: 27306316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.
    Green MF
    J Clin Psychiatry; 2006; 67 Suppl 9():3-8; discussion 36-42. PubMed ID: 16965182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Executive dysfunction and memory impairment in schizoaffective disorder: a comparison with bipolar disorder, schizophrenia and healthy controls.
    Amann B; Gomar JJ; Ortiz-Gil J; McKenna P; Sans-Sansa B; Sarró S; Moro N; Madre M; Landin-Romero R; Vieta E; Goikolea JM; Salvador R; Pomarol-Clotet E
    Psychol Med; 2012 Oct; 42(10):2127-35. PubMed ID: 22357405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do premorbid and post-onset cognitive functioning differ between schizophrenia and bipolar disorder? A systematic review and meta-analysis.
    Trotta A; Murray RM; MacCabe JH
    Psychol Med; 2015 Jan; 45(2):381-94. PubMed ID: 25065268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conducting clinical studies targeting cognition in psychiatry: guiding principles and design.
    Van Rheenen TE; Lewandowski KE; Lipschitz JM; Burdick KE
    CNS Spectr; 2019 Feb; 24(1):16-21. PubMed ID: 30244687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A meta-analysis of neuropsychological functioning in patients with early onset schizophrenia and pediatric bipolar disorder.
    Nieto RG; Castellanos FX
    J Clin Child Adolesc Psychol; 2011; 40(2):266-80. PubMed ID: 21391023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychological and functional outcomes in recent-onset major depression, bipolar disorder and schizophrenia-spectrum disorders: a longitudinal cohort study.
    Lee RS; Hermens DF; Naismith SL; Lagopoulos J; Jones A; Scott J; Chitty KM; White D; Robillard R; Scott EM; Hickie IB
    Transl Psychiatry; 2015 Apr; 5(4):e555. PubMed ID: 25918992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum levels of olanzapine are associated with acute cognitive effects in bipolar disorder.
    Shoshina II; Almeida NL; Oliveira MEC; Trombetta BNT; Silva GM; Fars J; Santos NA; Fernandes TP
    Psychiatry Res; 2022 Apr; 310():114443. PubMed ID: 35286918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide association study of cognitive performance in U.S. veterans with schizophrenia or bipolar disorder.
    Harvey PD; Sun N; Bigdeli TB; Fanous AH; Aslan M; Malhotra AK; Lu Q; Hu Y; Li B; Chen Q; Mane S; Miller P; Rajeevan N; Sayward F; Cheung KH; Li Y; Greenwood TA; Gur RE; Braff DL; ; Brophy M; Pyarajan S; O'Leary TJ; Gleason T; Przygodszki R; Muralidhar S; Gaziano JM; Concato J; Zhao H; Siever LJ
    Am J Med Genet B Neuropsychiatr Genet; 2020 Apr; 183(3):181-194. PubMed ID: 31872970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Functional Impairment in Patients with Bipolar Disorder.
    Sanchez-Moreno J; Martinez-Aran A; Vieta E
    Curr Psychiatry Rep; 2017 Jan; 19(1):3. PubMed ID: 28097635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Subjective cognition in schizophrenia].
    Potvin S; Aubin G; Stip E
    Encephale; 2017 Feb; 43(1):15-20. PubMed ID: 26923995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia.
    Zalla T; Joyce C; Szöke A; Schürhoff F; Pillon B; Komano O; Perez-Diaz F; Bellivier F; Alter C; Dubois B; Rouillon F; Houde O; Leboyer M
    Psychiatry Res; 2004 Jan; 121(3):207-17. PubMed ID: 14675740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linking resting-state networks and social cognition in schizophrenia and bipolar disorder.
    Jimenez AM; Riedel P; Lee J; Reavis EA; Green MF
    Hum Brain Mapp; 2019 Nov; 40(16):4703-4715. PubMed ID: 31322784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.